Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    November 2022
  1. ARRAMBIDE G, Espejo C, Carbonell-Mirabent P, Dieli-Crimi R, et al
    The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
    Brain. 2022;145:3931-3942.
    PubMed     Abstract available


  2. CORDANO C, Sin JH, Timmons G, Yiu HH, et al
    Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy.
    Brain. 2022;145:3943-3952.
    PubMed     Abstract available


  3. LIN X, Yang Y, Gresle M, Cuellar-Partida G, et al
    Novel plasma and brain proteins that are implicated in multiple sclerosis.
    Brain. 2022 Nov 8. pii: 6809197. doi: 10.1093.
    PubMed     Abstract available


  4. GARTON T, Gill AJ, Calabresi PA
    Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis.
    Brain. 2022 Nov 3. pii: 6794531. doi: 10.1093.
    PubMed    


  5. ROSTGAARD K, Nielsen NM, Melbye M, Frisch M, et al
    Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
    Brain. 2022 Nov 1. pii: 6783238. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  6. VAN STEENHOVEN RW, Titulaer MJ
    Seronegative autoimmune encephalitis: exploring the unknown.
    Brain. 2022 Sep 16. pii: 6701799. doi: 10.1093.
    PubMed    


  7. TONIETTO M, Poirion E, Lazzarotto A, Ricigliano V, et al
    Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
    Brain. 2022 Sep 13. pii: 6696508. doi: 10.1093.
    PubMed     Abstract available


  8. TEPAVCEVIC V, Lubetzki C
    Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Brain. 2022 Sep 12. pii: 6696052. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  9. AL-DIWANI A, Theorell J, Damato V, Bull J, et al
    Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
    Brain. 2022;145:2742-2754.
    PubMed     Abstract available


    July 2022
  10. GOVERT F, Abrante L, Becktepe J, Balint B, et al
    Distinct movement disorders in contactin-associated-protein-like-2 antibody associated autoimmune encephalitis.
    Brain. 2022 Jul 25. pii: 6649472. doi: 10.1093.
    PubMed     Abstract available


  11. BHARGAVA P, Hartung HP, Calabresi PA
    Contribution of B cells to cortical damage in multiple sclerosis.
    Brain. 2022 Jul 1. pii: 6623951. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  12. DADAR M, Mahmoud S, Narayanan S, Collins DL, et al
    Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
    Brain. 2022;145:2008-2017.
    PubMed     Abstract available


  13. RUCK T, Barman S, Schulte-Mecklenbeck A, Pfeuffer S, et al
    Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.
    Brain. 2022;145:1711-1725.
    PubMed     Abstract available


  14. BRADL M
    From astrocyte destruction to axon injury: watching lesion evolution in experimental neuromyelitis optica.
    Brain. 2022;145:1581-1583.
    PubMed    


  15. HERWERTH M, Kenet S, Schifferer M, Winkler A, et al
    A new form of axonal pathology in a spinal model of neuromyelitis optica.
    Brain. 2022;145:1726-1742.
    PubMed     Abstract available


  16. ADRICHEM ME, Lucke IM, Vrancken AFJE, Goedee HS, et al
    Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Brain. 2022;145:1641-1652.
    PubMed     Abstract available


  17. COLES A
    Campath, clones and the cause of autoimmunity.
    Brain. 2022;145:1579-1580.
    PubMed    


  18. MADSEN MAJ, Wiggermann V, Marques MFM, Lundell H, et al
    Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7 T MRI study.
    Brain. 2022 Jun 2. pii: 6599027. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  19. GUO Y, Lennon VA, Parisi JE, Popescu B, et al
    Spectrum of sublytic astrocytopathy in neuromyelitis optica.
    Brain. 2022;145:1379-1390.
    PubMed     Abstract available


  20. BERNARD-VALNET R, Frieser D, Nguyen XH, Khajavi L, et al
    Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy.
    Brain. 2022 May 13. pii: 6581499. doi: 10.1093.
    PubMed     Abstract available


  21. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    PubMed     Abstract available


  22. LEE WJ, Lee HS, Kim DY, Lee HS, et al
    Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes.
    Brain. 2022 May 5. pii: 6580901. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  23. CORNBLATH DR, van Doorn PA, Hartung HP, Merkies ISJ, et al
    Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy.
    Brain. 2022;145:887-896.
    PubMed     Abstract available


    March 2022
  24. STRIPPEL C, Herrera-Rivero M, Wendorff M, Tietz AK, et al
    A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
    Brain. 2022 Mar 28. pii: 6555060. doi: 10.1093.
    PubMed     Abstract available


  25. PORTACCIO E, Bellinvia A, Fonderico M, Pasto L, et al
    Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
    Brain. 2022 Mar 24. pii: 6553893. doi: 10.1093.
    PubMed     Abstract available


  26. SHAMS H, Shao X, Santaniello A, Kirkish G, et al
    Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.
    Brain. 2022 Mar 7. pii: 6542574. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  27. PERNIN F, Luo J, Cui QL, Blain M, et al
    Diverse injury responses of human oligodendrocyte to mediators implicated in multiple sclerosis.
    Brain. 2022 Feb 24. pii: 6535861. doi: 10.1093.
    PubMed     Abstract available


  28. KEH RYS, Scanlon S, Datta-Nemdharry P, Donegan K, et al
    COVID-19 vaccination and Guillain-Barre syndrome: analyses using the National Immunoglobulin Database.
    Brain. 2022 Feb 18. pii: 6532037. doi: 10.1093.
    PubMed     Abstract available


  29. LUBLIN FD, Haring DA, Ganjgahi H, Ocampo A, et al
    How patients with multiple sclerosis acquire disability.
    Brain. 2022 Feb 1. pii: 6519354. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  30. NISHIHARA H, Perriot S, Gastfriend BD, Steinfort M, et al
    Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.
    Brain. 2022 Jan 27. pii: 6516047. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  31. GREEN AJ
    Socioeconomic disadvantage in multiple sclerosis: does inequality act on the substrate for disability?
    Brain. 2021 Dec 20. pii: 6470562. doi: 10.1093.
    PubMed    


  32. CAROTENUTO A, Cacciaguerra L, Pagani E, Preziosa P, et al
    Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.
    Brain. 2021 Dec 17. pii: 6469024. doi: 10.1093.
    PubMed     Abstract available


  33. NTRANOS A, Park HJ, Wentling M, Tolstikov V, et al
    Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma.
    Brain. 2021 Dec 11. pii: 6459638. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  34. LIEBMANN M, Korn L, Janoschka C, Albrecht S, et al
    Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
    Brain. 2021;144:3126-3141.
    PubMed     Abstract available


  35. ZIEGLER D, Bonhof GJ, Strom A, Strassburger K, et al
    Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.
    Brain. 2021;144:3251-3263.
    PubMed     Abstract available


    October 2021
  36. VASILEIOU ES, Filippatou AG, Pimentel Maldonado D, Kalaitzidis G, et al
    Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis.
    Brain. 2021 Oct 29. pii: 6414110. doi: 10.1093.
    PubMed     Abstract available


  37. RODGERS J, Friede T, Vonberg FW, Constantinescu CS, et al
    The impact of smoking cessation on multiple sclerosis disease progression.
    Brain. 2021 Oct 8. pii: 6384574. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  38. LUIJTEN LWG, Leonhard SE, van der Eijk AA, Doets AY, et al
    Guillain-Barre syndrome after SARS-CoV-2 infection in an international prospective cohort study.
    Brain. 2021 Sep 23. pii: 6373760. doi: 10.1093.
    PubMed     Abstract available


  39. TAKAI Y, Misu T, Suzuki H, Takahashi T, et al
    Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
    Brain. 2021;144:2401-2415.
    PubMed     Abstract available


    August 2021
  40. NAUGHTON M, de la Fuente AG
    Autoantibodies and microglia: boon or bane?
    Brain. 2021 Aug 11. pii: 6348165. doi: 10.1093.
    PubMed    


    July 2021
  41. BENALLEGUE N, Kebir H, Kapoor R, Crockett A, et al
    The hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammation.
    Brain. 2021;144:1670-1683.
    PubMed     Abstract available


  42. JENSEN TS, Karlsson P, Gylfadottir SS, Andersen ST, et al
    Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management.
    Brain. 2021;144:1632-1645.
    PubMed     Abstract available


  43. MITSDOERFFER M, Di Liberto G, Dotsch S, Sie C, et al
    Corrigendum to: Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity.
    Brain. 2021 Jul 14. pii: 6321151. doi: 10.1093.
    PubMed    


    June 2021
  44. BITTNER S, Oh J, Havrdova EK, Tintore M, et al
    The potential of serum neurofilament as biomarker for multiple sclerosis.
    Brain. 2021 Jun 28. pii: 6310737. doi: 10.1093.
    PubMed     Abstract available


  45. COLLORONE S, Prados F, Kanber B, Cawley NM, et al
    Brain microstructural and metabolic alterations detected in vivo at onset of the first demyelinating event.
    Brain. 2021;144:1409-1421.
    PubMed     Abstract available


  46. HAIDER L, Prados F, Chung K, Goodkin O, et al
    Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
    Brain. 2021;144:1384-1395.
    PubMed     Abstract available


  47. PELLERIN K, Rubino SJ, Burns JC, Smith BA, et al
    MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response.
    Brain. 2021 Jun 18. pii: 6305830. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  48. GRANZIERA C, Wuerfel J, Barkhof F, Calabrese M, et al
    Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
    Brain. 2021 May 10. pii: 6273092. doi: 10.1093.
    PubMed     Abstract available


  49. VAN DOORN PA, Hadden RDM, Van den Bergh PYK
    Elucidating autoimmune nodopathies and the CIDP spectrum.
    Brain. 2021;144:1043-1045.
    PubMed    


  50. PASCUAL-GONI E, Fehmi J, Lleixa C, Martin-Aguilar L, et al
    Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
    Brain. 2021;144:1183-1196.
    PubMed     Abstract available


    April 2021
  51. FLECK AK, Hucke S, Teipel F, Eschborn M, et al
    Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity.
    Brain. 2021 Apr 26. pii: 6252379. doi: 10.1093.
    PubMed     Abstract available


  52. GHORBANI S, Yong VW
    The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis.
    Brain. 2021 Apr 23. pii: 6247173. doi: 10.1093.
    PubMed     Abstract available


  53. PARDINI M, Brown JWL, Magliozzi R, Reynolds R, et al
    Surface-in pathology in multiple sclerosis: a new view on pathogenesis?
    Brain. 2021 Apr 20. pii: 6238675. doi: 10.1093.
    PubMed     Abstract available


  54. PISA M, Croese T, Dalla Costa G, Guerrieri S, et al
    Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes.
    Brain. 2021 Apr 8. pii: 6215108. doi: 10.1093.
    PubMed     Abstract available


  55. LUCCHESE G, Floel A
    Guillain-Barre syndrome, SARS-CoV-2 and molecular mimicry.
    Brain. 2021 Apr 3. pii: 6209729. doi: 10.1093.
    PubMed    


  56. LUNN MP, Carr AC, Keddie S, Pakpoor J, et al
    Reply: Guillain-Barre syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barre syndrome and Unclear association between COVID-19 and Guillain-Barre syndrome and Currently avai
    Brain. 2021 Apr 3. pii: 6209732. doi: 10.1093.
    PubMed    


  57. FOSCHI M, D'Anna L, Abdelhak A, Mayer B, et al
    Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Apr 3. pii: 6209733. doi: 10.1093.
    PubMed    


  58. GONZALEZ DEL CASTILLO J, Porta-Etessam J, Miro O
    Currently available data regarding the potential association between COVID-19 and Guillain-Barre syndrome.
    Brain. 2021 Apr 3. pii: 6209731. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: